GIORGI, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 27.593
AS - Asia 14.688
EU - Europa 11.388
SA - Sud America 2.937
OC - Oceania 474
AF - Africa 411
Continente sconosciuto - Info sul continente non disponibili 17
Totale 57.508
Nazione #
US - Stati Uniti d'America 26.330
SG - Singapore 4.107
CN - Cina 3.745
IT - Italia 3.002
HK - Hong Kong 2.771
BR - Brasile 2.168
GB - Regno Unito 1.302
VN - Vietnam 1.204
PL - Polonia 1.021
SE - Svezia 995
BG - Bulgaria 935
CA - Canada 901
DE - Germania 734
TR - Turchia 657
FR - Francia 569
RU - Federazione Russa 547
FI - Finlandia 484
IN - India 483
UA - Ucraina 422
AU - Australia 398
JP - Giappone 343
KR - Corea 329
CL - Cile 258
MX - Messico 242
CH - Svizzera 237
NL - Olanda 224
ES - Italia 195
AR - Argentina 162
BD - Bangladesh 156
ID - Indonesia 153
CO - Colombia 109
AT - Austria 97
IE - Irlanda 96
IQ - Iraq 92
PT - Portogallo 92
IR - Iran 90
ZA - Sudafrica 85
EG - Egitto 84
EC - Ecuador 83
GR - Grecia 80
BE - Belgio 78
PK - Pakistan 78
NZ - Nuova Zelanda 76
TH - Thailandia 76
TW - Taiwan 65
PE - Perù 53
VE - Venezuela 52
CI - Costa d'Avorio 45
RO - Romania 43
SA - Arabia Saudita 43
CZ - Repubblica Ceca 36
UZ - Uzbekistan 36
JO - Giordania 35
MY - Malesia 35
PH - Filippine 35
MA - Marocco 34
DK - Danimarca 33
HU - Ungheria 33
SN - Senegal 33
CR - Costa Rica 28
NP - Nepal 25
DZ - Algeria 23
IL - Israele 23
KE - Kenya 21
LV - Lettonia 21
TN - Tunisia 20
UY - Uruguay 19
NG - Nigeria 18
NO - Norvegia 18
PY - Paraguay 18
JM - Giamaica 16
AE - Emirati Arabi Uniti 15
KZ - Kazakistan 15
ET - Etiopia 14
PA - Panama 14
BO - Bolivia 13
KH - Cambogia 13
LT - Lituania 13
EU - Europa 12
GT - Guatemala 11
SK - Slovacchia (Repubblica Slovacca) 11
AZ - Azerbaigian 10
BJ - Benin 10
RS - Serbia 10
OM - Oman 9
BY - Bielorussia 8
EE - Estonia 8
TT - Trinidad e Tobago 8
AL - Albania 7
BB - Barbados 7
DO - Repubblica Dominicana 7
HR - Croazia 7
MT - Malta 7
BN - Brunei Darussalam 6
HN - Honduras 6
KG - Kirghizistan 6
LY - Libia 6
PS - Palestinian Territory 6
BH - Bahrain 5
MK - Macedonia 5
Totale 57.420
Città #
Woodbridge 3.020
Hong Kong 2.732
Ashburn 2.293
Singapore 2.271
Ann Arbor 1.963
Houston 1.809
Fairfield 1.736
Chandler 1.356
San Jose 1.277
Santa Clara 1.004
Milan 946
Dallas 935
Sofia 932
Beijing 851
Seattle 737
Shanghai 731
Wilmington 702
New York 648
Cambridge 621
Jacksonville 596
Ottawa 584
Serra 468
Princeton 467
Boardman 425
Lawrence 379
Izmir 356
Medford 340
Lauterbourg 337
Nanjing 334
Hefei 327
Ho Chi Minh City 270
Los Angeles 269
Tokyo 268
Redwood City 264
Seoul 252
Council Bluffs 236
Des Moines 206
Bern 182
Hanoi 182
Istanbul 174
São Paulo 172
Rome 146
Buffalo 143
Dearborn 141
Redondo Beach 141
Dong Ket 134
Santiago 133
Nanchang 120
Menlo Park 114
Helsinki 111
San Diego 109
Jüchen 108
London 106
Sydney 92
Munich 90
Boulder 82
Columbus 82
Frankfurt am Main 82
Shenyang 82
Falls Church 81
Montréal 71
The Dalles 71
Vienna 70
Manchester 67
Rio de Janeiro 66
Kunming 65
Hebei 64
Guangzhou 61
Melbourne 61
Bogotá 60
Ogden 59
Khulna 58
Changsha 57
Ames 55
Mumbai 54
Pune 53
Tianjin 53
Curitiba 52
Orem 51
Pisa 48
Brisbane 46
Cairo 46
Abidjan 44
Amsterdam 44
Belo Horizonte 44
Chennai 44
Norwalk 44
Jakarta 43
Jiaxing 43
Fuzhou 41
Hangzhou 41
Mcallen 40
Bristol 39
Brasília 38
Montreal 38
Chicago 37
Mexico City 37
Utrecht 37
Warsaw 37
Porto Alegre 36
Totale 37.764
Nome #
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats 3.709
Paracetamol: A Focus on Dogs 1.492
DEVELOPMENT AND VALIDATION OF A NEW HPLC-FLUORIMETRIC METHOD TO DETERMINE EPIRUBICIN AND ITS METABOLITEEPIRUBICINOL IN DOG PLASMA 1.032
ANTINOCICEPTIVE PROPERTIES OF HYDRO ALCOHOLIC EXTRACTS OF ANETHUM GRAVEOLENS L. (DILL) SEED AND AERIAL PARTS IN MICE 443
BIOPHARMACEUTICS OF METOCLOPRAMIDE: INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND PER RECTUM ADMINISTRATIONS IN RABBITS 430
CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients 337
A BRIEF OVERVIEW OF THE COXIB DRUGS IN THE VETERINARY FIELD 308
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation 281
MIRTAZAPINE IN BEAGLE DOGS 277
Novel LC-MS/MS method for CJ-023423 (Grapiprant) determination in rabbit plasma 269
Pharmacokinetics of Bedrocan (marijuana extract oil) in fasted and fed dogs: a pilot study 267
EVALUATION OF PLASMA DETECTABLE CONCENTRATIONS OF TWO LIDOCAINE TRANSDERMAL FORMULATIONS AND THEIR ANALGESIC EFFECT IN THE HORSE 244
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 240
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 240
Analytical Method Validation of Vilazodone with Spectrofluorimetric Detection in Rabbit Plasma 236
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment 235
Anticonvulsant activity of hydroalcoholic phoenix dactylifera fruit extract and pimpinella anisum oil in mice 226
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 222
Natural substances as new potential strategies for the treatment of Leishmaniosisin Dogs 218
USE OF A LASERCYTE® FOR THE COMPLETE BLOOD COUNT IN DOGS WITH ONCOHEMATOLOGICAL DISORDERS 216
Bioanalytical Method Validation and Quantification of Flupirtine in Canine Plasma by HPLC with Spectrofluorimetric Detection 216
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENTS OF 10 MG/KG TRAMADOL INTRAMUSCULAR INJECTION IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA). 215
Pharmacokinetic and pharmacodynamic evaluations of levofloxacin in broiler chickens 215
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 206
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 203
INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES 197
PILOT IN VIVO TOXICOLOGICAL INVESTIGATION OF BORON NITRIDE NANOTUBES 196
Gabapentin in Cattle: A Pharmacology Snapshot 189
NEW HPLC METHOD TO DETECT INDIVIDUAL OPIOIDS (HEROIN AND TRAMADOL) AND THEIR METABOLITES IN THE BLOOD OF RATS ON COMBINATION TREATMENT 189
Pharmacokinetics of Sulpiride Following Intravenous, Intramuscular and Oral Single Dose Administration in Nurse Mares 189
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs 185
Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit 183
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM AFTER ORAL ADMINISTRATION OF A SINGLE DOSE IN DOGS 182
COMPARISON OF INJECTABLE PARECOXIB VERSUS ROBENACOXIB FOR PERI-OPERATIVE USE IN DOGS: PRELIMINARY RESULTS 182
PHARMACOKINETICS OF METHYLPHENIDATE AFTER ORAL ADMINISTRATION OF IMMEDIATE AND SUSTAINED RELEASE PREPARATIONS IN BEAGLE DOGS 181
Pharmacokinetics of Metoclopramide After IntraARTERIAL, Intramuscular, Subcutaneous, and Perrectal Administration in Rabbits 181
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes 181
ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE 179
BIOCOMPATIBILITY OF BORON NITRIDE NANOTUBES: AN UP-DATE OF IN VIVO TOXICOLOGICAL INVESTIGATION 179
Validation of an HPLC-FL method for the determination of tepoxalin and its major metabolite in horse plasma 178
PHARMACOKINETIC INVESTIGATIONS OF THE MARKER ACTIVE METABOLITE-4-METHYLAMINO-ANTIPYRIN AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF METAMIZOLE IN HEALTHY SHEEP 178
Pharmacokinetics of Bedrocan®, a cannabis oil extract, in fasting and fed dogs: An explorative study 177
PHARMACOKINETICS OF METHYLPHENIDATE FOLLOWING TWO ORAL FORMULATIONS (IMMEDIATE AND SUSTAINED RELEASE) IN THE DOG 176
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 176
A BRIEF OVERVIEW OF OUR CURRENT UNDERSTANDING OF NIVALENOL: A GROWING POTENTIAL DANGER YET TO BE FULLY INVESTIGATED 176
CLINICAL INTERACTION BETWEEN GRAPEFRUIT-JUICE AND CYCLOSPORINE: IS THERE ANY INTEREST FOR VETERINARY MEDICINE? 175
A comparative kinetic study of thiamphenicol in pre-ruminant lambs and calves 175
Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers 175
QUANTIFICATION OF TAPENTADOL IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 174
Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection 173
PHARMACOKINETIC PROFILES OF THE NOVEL COX-2 SELECTIVE INHIBITOR CIMICOXIB IN DOGS 172
Pharmacokinetics of levosulpiride after single-dose administration by different routes in sheep (Ovis aries Linnaeus) 172
PHARMACOKINETCIS STUDY OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING HENS AFTER SINGLE AND MULTIPLE TREATMENT BY A NEW HPLC METHOD 171
PHARMACOKINETIC OF TRAMADOL AND ITS MAJOR CONJUGATES AFTER SINGLE PER OS ADMINISTRATION OF THE SUSTAINED TABLET AND PER RECTUM SUPPOSITORIES FORMULATIONS IN DOGS 171
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 170
Analgesici oppiodi: HPLC-FL e LC-UV-ESI-MS/MS per la determinazione simultanea del tramadolo e dei suoi metaboliti nel plasma di cavallo 170
Pharmacokinetics and disposition of flupirtine in the horse 170
ANIMAL POISONING FREQUENCY IN CENTRAL ITALY (YEARS 2003-2004) 169
GLI ANALGESICI IN MEDICINA VETERINARIA. Animali da compagnia (oppioidi, a2 agonisti e ketamina) 169
Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): A preliminary assessment 169
hCG is more effective than the GnRH agonist buserelin for inducing the first ovulation of the breeding season in mares 169
CLINICAL AND HEMATOLOGICAL ADVERSE EFFECTS AFTER ADMINISTRATION OF TWO DIFFERENT CHEMOTHERAPY PROTOCOLS IN DOGS AFFECTED BY LYMPHOMA 168
Role of Natural Products in Ameliorating Drugs and Chemicals Toxicity 166
Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs 166
Cardiovascular effects and intraoperative pharmacokinetics of tramadol in sheep undergoing spinal surgery 166
BIOGENIC AMINE CONTENT IN “PECORINO DEL PARCO DI MIGLIARINO - SAN ROSSORE” 165
ORAL ADMINISTRATION OF TEPOXALIN IN THE HORSE: A PK/PD STUDY 165
DETECTION AND QUANTIFICATION OF CIMICOXIB, A NOVEL COX-2 INHIBITOR, IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 165
Pharmacokinetic Assessment of the Marker Active Metabolites 4-Methyl-amino-antipyrine and 4-Acetyl-amino-antipyrine After Intravenous and Intramuscular Injection of Metamizole (Dipyrone) in Healthy Donkeys 165
Cebranopadol, a novel first-in-class drug candidate: Method validation and first exploratory pharmacokinetic study in rabbits 165
A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF IOHEXOL AND p-AMINOHIPPURIC ACID IN PLASMA OF DOGS 164
LABORATORY DIAGNOSTIC EXAMINATIONS IN VETERINARY TOXICOLOGY 164
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS AT TWO DOSE RATES 164
Effect of feeding on the pharmacokinetics of vilazodone in dogs 164
MIRTAZAPINE IN VETERINARY MEDICINE A PHARMACOLOGICAL RATIONALE FOR ITS APPLICATION IN CHRONIC PAIN 162
A new HPLC method to determine glomerular filtration rate and effective renal plasma flow in conscious dogs by single intravenous administration of iohexol and p-aminohippuric acid 162
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 162
BLOOD CONCENTRATION OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA), AFTER A SINGLE INTRACOELOMIC INJECTION OF ENROFLOXACIN 161
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE ORAL ADMINISTRATION IN FASTING/FED HORSES 161
DETECTION AND QUANTIFICATION OF THE SELECTIVE EP4 RECEPTOR ANTAGONIST CJ-023423 (GRAPIPRANT) IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION 160
Pharmacokinetics of levosulpiride after single-dose administration in goats (Capra hircus) by different routes of administration 160
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 159
PHARMACOKINETICS OF THE NOVEL ATYPICAL OPIOID TAPENTADOL FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION IN DOGS 159
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4 '-hydroxy praziquantel in beagle dogs 159
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 159
Impact of low-dose ozone supplementation on motility parameters and bacterial growth in horse cryopreserved semen 159
HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC DETERMINATION OF THALIDOMIDE IN PATIENTS AFFECTED BY HEPATOCELLULAR CARCINOMA 158
IN SITU FORMING GEL LIKE DEPOT OF A POLYASPARTAMIDE-POLYLACTIDE COPOLYMER FOR ONCE A WEEK ADMINISTRATION OF SULPIRIDE 158
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 157
CONSTRUCTION AND EVALUATION OF SPONGE SCAFFOLDS FROM HYALURONIC ACID DERIVATIVES FOR POTENTIAL CARTILAGE REGENERATION 157
Exposure assessment of multiple mycotoxins in black and white sesame seeds consumed in Thailand 157
THE PHARMACOKINETICS AND IN VITRO/EX VIVO CYCLOOXYGENASE SELECTIVITY OF PARECOXIB AND ITS ACTIVE METABOLITE VALDECOXIB IN CATS 156
Apoptosis and gene expression in Jurkat human T cells and lymphoid tissues of fusarenon-X-treated mice 156
Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs 155
EU PERSPECTIVES OF BIOEQUIVALENCE TEST FOR THE APPROVAL OF GENERIC VETERINARY MEDICINAL PRODUCTS. THE ROLE OF EXCIPIENTS 155
CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS 155
The role of clomipramine in potentiating the teratogenic effects of caffeine in pregnant rats: a histopathological study 155
Clinical studies of metronomic chemotherapy in dogs 155
PHARMACOKINETIC PROFILES OF THE ANALGESIC DRUG FLUPIRTINE IN CATS 154
PHARMACOKINETICS OF DIFFERENT FORMULATIONS OF TRAMADOL IN THE HORSE 153
Totale 24.626
Categoria #
all - tutte 151.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021866 0 0 0 0 0 0 0 0 0 0 264 602
2021/20224.397 149 304 155 303 720 604 134 251 215 160 268 1.134
2022/20233.898 548 364 298 385 513 565 88 295 564 34 188 56
2023/20246.088 622 547 526 402 668 782 218 328 136 1.089 309 461
2024/202511.967 135 546 186 644 871 972 1.012 900 1.434 1.832 1.361 2.074
2025/202612.620 678 1.580 1.488 1.228 1.028 1.321 1.797 781 959 1.335 425 0
Totale 58.487